A 37-year-old heating, ventilation, and air-conditioning mechanic developed respiratory, musculoskeletal, and central nervous system symptoms associated with a variety ofodorous environmental chemicals. Organic disease was not evident, but the patient was distressed by these symptoms and was at risk for becoming disabled by them. His symptoms fit broadly into the condition recognized as multiple chemical sensitivity. Multiple We recommended a methacholine challenge, which was declined by the patient; we also recommended counseling to improve his understanding of and his response to his symptoms. We informed the patient that we did not feel he was disabled and that he could continue to work using a respirator as required. We informed his employer that he was able to use a respirator, and should be permitted to wear one on the job at his own discretion.
referred in 1992 for further evaluation of headaches and chest tightness. He described excellent health until a day in November 1991, when he removed a panel from an airconditioning unit and inhaled an unknown gas or vapor, which produced face, nose, and throat irritation. He developed a cough, sore throat, and dizziness, but completed his day at work. Irritation resolved over a long weekend, but shortness of breath progressed until he saw his primary care physician 5 days later. The patient's physician determined that he had symptoms of bronchospasm and a decreased forced vital capacity; he was given bronchodilators and was told to take 2 weeks off from work. Most symptoms resolved; however, after the patient returned to work, he noted that exposure to a number of agents (including cigarette smoke, laundry detergent, ammonia, air fresheners, cleaning sprays, garden sprays, and paint fumes), whether at home or work, gave him the following immediate symptoms: a foul taste in his mouth, gagging, eye irritation, chest tightness, nonproductive cough, myalgias, and arthralgias. After the exposures he noted significant fatigue, a "spacy" feeling, and headaches. Blood work, a repeat spirometry, lung volumes, diffusing capacity, and arterial blood gas were all normal. He purchased a half-face organic vapor respirator that he wore on the job, which resulted in a reduction in negative reactions. His symptoms continued to improve despite stopping all bronchodilator and other medications, although milder systemic reactions persisted.
Past history. In 1990, while taking care of his 5-year-old and 8-month-old children when his wife was hospitalized, he developed a transient anxiety disorder, which responded to anxiolytics. He had no atopic history or history of respiratory disease. He was a nonsmoker and used alcohol infrequently.
Examination. The patient was anxious about his situation; he felt helpless to prevent his sensitivity reactions We recommended a methacholine challenge, which was declined by the patient; we also recommended counseling to improve his understanding of and his response to his symptoms. We informed the patient that we did not feel he was disabled and that he could continue to work using a respirator as required. We informed his employer that he was able to use a respirator, and should be permitted to wear one on the job at his own discretion.
Discussion
There is no widely accepted definition of multiple chemical sensitivities (MCS) because there is very little agreement on what the symptoms represent. No definition has yet been generally endorsed for clinical use by a recognized body of physicians (1, 2) . Nevertheless, there is a group(s) of patients who present in a way (3, 4) that leads us to consider this topic; in fact, it is clinically important and useful to recognize their distinctions from and overlaps with other diagnostic categories (3). Recognition, evaluation, and treatment can be done from within a perspective of traditional allopathic, scientifically based practice.
MCS is most useful to distinguish persons with medically unexplained symptoms (e.g., fatigue, headache, concentration problems, and respiratory symptoms) when those symptoms are attributed to and are triggered by environmental exposures, as there is no other specific diagnostic label to describe such individuals. Many advocates of the concept of chemical sensitivity, such as the group of environmental physicians formerly (6) and those who endorse three or four of these behavioral items (8) .
A major practical limitation of all available definitions of MCS is the subjectivity and nonspecificity of the available information regarding the predictable and demonstrable attributes of the exposure-symptom relationship. Whereas this relationship might be most meaningfully established by doubleblinded and controlled exposure challenge testing, it is usually characterized solely on the basis of the patient's report. Other proposed definitions, and even other names, have been published, but none has been validated, subjected to substantial review, or achieved widespread acknowledgment (9,10).
Classification and natural history.
Although there is no clear definition for MCS, the available literature suggests useful guides for individual patients, especially in terms of comorbidity and severity. A key consideration is whether or not there is a diagnosable psychiatric condition. Higher rates of diagnosable psychiatric conditions exist when MCS subjects have been compared to controls (11) . Although rates are not necessarily higher than for other groups of patients with unexplained symptoms, rates of diagnosable psychiatric conditions may reach 50%, sometimes 70%, which is far higher than in the general population. There is also a high correlation between the presence of psychiatric comorbidity and whether the MCS is reported to have a clear, defining onset, as in the first Cullen criterion (lower psychiatric comorbidity), or whether it developed gradually without a sudden overexposure incident (higher psychiatric comorbidity) (8) .
Patients frequently attribute changes in severity of symptoms to control or lack of exposure, but this has not been carefully studied. One study suggests that self-reported reduction of exposure is an important determinant of well-being, but it was not associated with reduction in actual reported symptoms (12) . MCS is not known to be progressive in terms of measurable physical dysfunction or development of medical complications. Symptomatic reactions to chemicals tend to persist, although some individuals (such as the patient in this case) learn to cope with such symptoms and achieve relatively normal levels of function, remaining employed.
Epidemiology. No population-based studies have been published on the prevalence or incidence of MCS according to the definitions used here. Neverthess, the prevalence of self-reported sensitivity to chemicals (15%) and the prevalence of self-reported receipt of a physician diagnosis of MCS (6%) has now been reported in a rigorous epidemiologic survey (4), confirming earlier reports of high rates of chemical sensitivity symptoms (13, 14 (26) . There are currently no data on the association of hyperventilation with MCS symptoms, but this is one mechanism for production of symptoms in multiple systems.
Volume 108, Number 4, April 2000 * Environmental Health PerspectivesSome intriguing case reports have associated organic solvents with panic attacks (22, 27, 28) . The substantial importance of panic attacks in some cases of otherwise unexplained symptoms has been recently reviewed by Smoller et al. (29) . For cases in which one or more chemical odors trigger either typical or limited panic attacks, the designation of "odor-triggered panic attacks or panic disorder" has been proposed (30) . Other theories of causation of MCS include more complex biologic mechanisms for the conditioning model described above, relying upon interaction between the olfactory, nervous, and endocrine systems to explain odortriggered symptoms (17, 31) .
Beliefrystems. In some individuals, MCS is characterized by a belief system (17) ; this is consistent with the increasing concern of the public regarding environmental pollution and health effects of exposure to manmade chemicals (32, 33 (34) .
The exposure history is fundamental for an understanding of potential causal factors. In addition to establishing the history of symptoms triggered by exposures that are tolerated by most people, it is important to determine the circumstances of the initiating exposure. The exdusion of traditional toxic conditions, particularly irritant-induced asthma and toxic encephalopathy, and the consideration of the toxin-related anxiety syndromes such as post-traumatic stress disorder and toxin-induced panic attacks must be addressed. It must be determined whether the exposure was substantially unusual, such as an accident, the evacuation of a building, or another circumstance, raising the possibility of both chemical damage and psychologic trauma. The physician should estimate concentration and duration of exposures to allow for the determination of the probability that the symptoms are attributable to a known toxic or irritant effect.
Physical examinations are performed largely to identify other medical conditions. Diagnostic testing. The evaluating and the treating physician must be wary about excessive ordering as well as the misinterpretation of diagnostic tests because these may reinforce a detrimental pattern of illness behavior (35 (37. There is a widespread assertion that MCS could be characterized by abnormalities of immune system activation, lymphocyte subtypes, and autoantibodies, which has been studied in a limited number of controlled trials. No form of immunologic testing has been shown to effectively diagnose either exposure to specific chemicals or illness due to exposure in patients with MCS (11) .
Neuropsychologic testing is dependent on patient cooperation and may be useful to rule out other conditions in the differential diagnosis. At present, neuropsychologic testing does not reveal consistent or specific findings in MCS patients that can be used for diagnosis (8, 38) .
Definitive research on controlled challenge procedures using appropriate controls is necessary before these procedures can be recommended as tools for diagnosis (39) (40) (41) .
Psychiatri evaluation. Psychiatric evaluation may be appropriate for some patients diagnosed with MCS, given the high prevalence of coexisting or preexisting psychiatric disorders in these patients. Unfortunately, many patients given a diagnosis of MCS resist the idea that psychologic factors may play any etiologic role at all in their distress; however, this should not necessarily be interpreted that the patient has a primary psychiatric illness. The stigma placed on psychiatric disorders in our society probably plays a major role in the tendency to somatize. The adamant rejection of psychologic factors in symptom formation and expression by MCS patients is a challenge for the physician, who must establish a workable strategy for approaching this issue that is both sensitive to the patient's feelings and effective in exploring possible emotional contributors to the syndrome (35) . For (17, 42, 43 Hyperventilation should be identified and approached through breathing control, stress management, and education. More severe symptoms of depression or anxiety should be medically managed with psychotropics. Based on our experience, if psychiatric medications are used, they must be given at very low doses and then titrated up to give these patients time to adjust to potential side effects, which are anecdotally reported to be more problematic in these individuals and others with medically unexplained physical symptoms (48) .
Cognitive behavioral therapy for medically unexplained symptoms, not specifically including MCS, has been shown to be effective in two randomized trials, with a returnto-work rate of up to 70% in one study (46, 44. Guglielmi et al. (48) identified three MCS patients who met criteria for simple phobia and who were, at least initially, successfully treated by an intensive desensitization program consisting of biofeedbackassisted relaxation training, in vivo exposure to offending chemicals, and cognitive restructuring procedures.
Odors and exposure to volatile organic compounds in the workplace and home, which are perceived as irritating or noxious by the symptomatic person, should be reduced and controlled as much as possible.
Conclusions
Although it is often disputed whether the symptoms of MCS have a functional or organic basis, it is necessary to have an informed approach to evaluation, diagnosis, and management and a careful assessment of impairment, disability, and work-relatedness. It is optimal to have an integrated medical and psychologic approach with careful exclusion of organic causes, followed by a judicious approach to coping. Those patients who, after supportive counseling, continue to deny that stress or psychologic factors may play any role at all in their symptoms probably cannot be helped by any of the above behaviorally based therapies. The patient who we described sought counseling at another facility near his home and remained at his job, although various sensitivity reactions continue.
